BioSpace News Archive

Biotech Beach

Celebrity Fitness Coach, Dolvett Quince’s, ‘Empowered in Paradise’ Wellness Adventure & Fitness Retreat to Debut Nov. 8-11 at The Hilton Sedona Resort, Sedona, Arizona

Dolvett Quince, Celebrity Fitness Coach known for his tenacious yet motivating workouts, has launched a new wellness experience called Empowered in Paradise (EIP).

October 23, 2018
·
2 min read
Pharm Country

AmeriHealth Caritas Opioid Blueprint Demonstrates Benefits of Managed Care in Preventing and Combating Substance Use Disorders

AmeriHealth Caritas, a national leader in Medicaid managed care and other health care solutions for those most in need, announced today the impact of its proprietary Opioid Blueprint

October 23, 2018
·
8 min read
BioCapital

APhA to Attend White House Event on Nation’s Opioid Epidemic

The American Pharmacists Association (APhA) has been invited to the White House on Wednesday to participate in an event to commemorate the many efforts to curb the national opioid crisis.

October 23, 2018
·
2 min read
Business

Amgen Announces 2018 Fourth Quarter Dividend

Amgen today announced that its Board of Directors declared a $1.32 per share dividend for the fourth quarter of 2018.

October 23, 2018
·
5 min read
Business

Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2019 on October 30, 2018

Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the first quarter of fiscal 2019 and hold a conference call to discuss those results on Tuesday, October 30, 2018.

October 23, 2018
·
1 min read
BioMidwest

Upsher-Smith Launches Generic Version Of Onfi® (clobazam), CIV In Tablet And Oral Suspension Dosage Forms

Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced the launch of Clobazam Tablets, CIV, 10 and 20 mg and Clobazam Oral Suspension, CIV, 2.5 mg/mL. Upsher-Smith’s Clobazam products are AB-rated to the branded products, Onfi® (clobazam) tablets, CIV and Onfi® (clobazam) oral suspension, CIV.

October 23, 2018
·
2 min read
Deals

InDex Pharmaceuticals Carries Out a Directed Share Issue of Approximately SEK 37.5 Million

The board of directors of InDex Pharmaceuticals Holding AB (publ) (the “Company” or “InDex”) has, with support from the authorization granted by the annual general meeting on May 24, 2018, resolved on a directed share issue of 6,252,842 shares to a small group of investors.

October 23, 2018
·
5 min read
Mallinckrodt and the Lupus Foundation of America Present Data from Survey of Over 1,500 Individuals with Self-Reported Lupus at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting

Study finds individuals with lupus experience a high disease flare burden and as a result engage in preventive and treatment measures

October 23, 2018
·
8 min read
Deals

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) on October 17, 2018

PTC Therapeutics, Inc. today announced that on October 17, 2018 it approved non-statutory stock options to purchase an aggregate of 68,700 shares of its common stock to 13 new employees.

October 23, 2018
·
1 min read
Business

Marker Therapeutics, Inc. Announces New Executive Appointments

Marker Therapeutics, Inc. today announced the addition of four senior executives to its executive management team.

October 23, 2018
·
8 min read